Developmental toxicity of remdesivir, an anti‐COVID‐19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells is a research paper published in Birth Defects Research (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Child Health and Human Development
Grant: R03 HD101735
National Institute of Child Health and Human Development
Grant: R03 HD102502
National Institute of General Medical Sciences
Grant: P30 GM131944
NICHD NIH HHS
Grant: R03 HD110743
National Institutes of Health
Grant: 5R03HD101735-02
In vitro molecular interrogation of SSRI antidepressants for teratogenic potential
National Institutes of Health
Grant: 5R03HD102502-02
Human pluripotent stem cell-based assessment of dolutegravir teratogenicity
National Institutes of Health
Grant: 5P30GM131944-03
IBR-COBRE Phase III
Alternatives Research and Development Foundation
Alternatives Research and Development Foundation
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals